Tech Company Financing Transactions

Indigo Biosciences Funding Round

Indigo Biosciences closed a $500 thousand Series B funding round on 8/4/2016. Investors included private investors.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
INDIGO'S latest financing will be used to accelerate growth through new product development, continued development of a European strategy, and the expansion of domestic sales capabilities. This Series B financing is part of an overall goal to raise $1.5 million in investments.

Company Information

Company Status
Private & Independent
Mailing Address
3006 Research Dr. A1
State College, PA 16801
Email Address
INDIGO's mission is to provide innovative products and services to improve the speed, cost and risk in the drug discovery process.
Indigo Biosciences LinkedIn Company Profile
Social Media
Indigo Biosciences Company Twitter Account
Company News
Indigo Biosciences News
Indigo Biosciences on Facebook
Indigo Biosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Fred Marroni
  Fred Marroni LinkedIn Profile  Fred Marroni Twitter Account  Fred Marroni News  Fred Marroni on Facebook
Chief Scientific Officer
Jack Heuvel
  Jack Heuvel LinkedIn Profile  Jack Heuvel Twitter Account  Jack Heuvel News  Jack Heuvel on Facebook
Chief Technical Officer
Bruce Sherf
  Bruce Sherf LinkedIn Profile  Bruce Sherf Twitter Account  Bruce Sherf News  Bruce Sherf on Facebook



Browse more venture capital transactions:

Prev: 8/4/2016: Velostrata venture capital transaction
Next: 8/4/2016: Ceros venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data is sourced from, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary